Anders Morén
CFO since 2023
B.Sc in Business Administration from the University of Uppsala. Anders has a background in Auditing and 30 years of experience in the Life Sciences Industry where he has held various positions within Finance and Business Development in companies like Baxter, Roche, Merck & Co., and Gilead Sciences.
Holdings: 77 440 B-shares, 17 000 SSP 24/27: 1 RSU and 51 000 SSP 24/27:1 PRSU.
>4,500
Numbers of patients in studies
28
Publications
22
Pharma Projects